Details der Publikation - South Africa ushers in a new era for HIV

South Africa ushers in a new era for HIV

Medienart:	Artikel

Erscheinungsjahr:	2016
Erschienen:	2016

Enthalten in:	Zur Gesamtaufnahme - volume:535
Enthalten in:	Nature - 535(2016), 7611, Seite 214-217

Sprache:	Englisch

Beteiligte Personen:	Nordling, Linda [VerfasserIn]

Links:	Volltext www.ncbi.nlm.nih.gov

Themen:	Acquired Immunodeficiency Syndrome - drug therapy Acquired Immunodeficiency Syndrome - epidemiology Acquired Immunodeficiency Syndrome - transmission Anti-HIV Agents - administration & dosage Anti-HIV Agents - supply & distribution Anti-HIV Agents - therapeutic use Congresses as Topic - history HIV Infections - drug therapy HIV Infections - epidemiology HIV Infections - transmission Infectious Disease Transmission, Vertical - prevention & control Patient Acceptance of Health Care - psychology Prenatal Exposure Delayed Effects - epidemiology Public Health - methods

doi:	10.1038/535214a

funding:
Förderinstitution / Projekttitel:

PPN (Katalog-ID):	OLC1982119403

Internformat


LEADER	01000caa a2200265 4500
001	OLC1982119403
003	DE-627
005	20230714213923.0
007	tu
008	161013s2016 xx \|\|\|\|\| 00\| \|\|eng c
024	7		\|a 10.1038/535214a \|2 doi
028	5	2	\|a PQ20161012
035			\|a (DE-627)OLC1982119403
035			\|a (DE-599)GBVOLC1982119403
035			\|a (PRQ)c557-6716dacb480b64657807799d8f949ced1908644fa25c62b19bede6bce7dda02b0
035			\|a (KEY)0072945020160000535761100214southafricaushersinaneweraforhiv
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
082	0	4	\|a 070 \|a 500 \|q DE-101
082	0	4	\|a 500 \|q AVZ
084			\|a BIODIV \|2 fid
100	1		\|a Nordling, Linda \|e verfasserin \|4 aut
245	1	0	\|a South Africa ushers in a new era for HIV
264		1	\|c 2016
336			\|a Text \|b txt \|2 rdacontent
337			\|a ohne Hilfsmittel zu benutzen \|b n \|2 rdamedia
338			\|a Band \|b nc \|2 rdacarrier
650		4	\|a Prenatal Exposure Delayed Effects - epidemiology
650		4	\|a Acquired Immunodeficiency Syndrome - drug therapy
650		4	\|a Patient Acceptance of Health Care - psychology
650		4	\|a HIV Infections - transmission
650		4	\|a Anti-HIV Agents - therapeutic use
650		4	\|a Anti-HIV Agents - administration & dosage
650		4	\|a Anti-HIV Agents - supply & distribution
650		4	\|a HIV Infections - epidemiology
650		4	\|a Congresses as Topic - history
650		4	\|a Acquired Immunodeficiency Syndrome - transmission
650		4	\|a Public Health - methods
650		4	\|a Acquired Immunodeficiency Syndrome - epidemiology
650		4	\|a HIV Infections - drug therapy
650		4	\|a Infectious Disease Transmission, Vertical - prevention & control
773	0	8	\|i Enthalten in \|t Nature <London> \|d London : Macmillan, 1869 \|g 535(2016), 7611, Seite 214-217 \|w (DE-627)129292834 \|w (DE-600)120714-3 \|w (DE-576)014473941 \|x 0028-0836 \|7 nnns
773	1	8	\|g volume:535 \|g year:2016 \|g number:7611 \|g pages:214-217
856	4	1	\|u http://dx.doi.org/10.1038/535214a \|3 Volltext
856	4	2	\|u http://www.ncbi.nlm.nih.gov/pubmed/27411617
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_OLC
912			\|a FID-BIODIV
912			\|a SSG-OLC-PHY
912			\|a SSG-OLC-CHE
912			\|a SSG-OLC-MAT
912			\|a SSG-OLC-FOR
912			\|a SSG-OLC-SPO
912			\|a SSG-OLC-PHA
912			\|a SSG-OLC-DE-84
912			\|a SSG-OPC-FOR
912			\|a GBV_ILN_11
912			\|a GBV_ILN_14
912			\|a GBV_ILN_22
912			\|a GBV_ILN_30
912			\|a GBV_ILN_40
912			\|a GBV_ILN_47
912			\|a GBV_ILN_48
912			\|a GBV_ILN_59
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_69
912			\|a GBV_ILN_70
912			\|a GBV_ILN_73
912			\|a GBV_ILN_101
912			\|a GBV_ILN_110
912			\|a GBV_ILN_120
912			\|a GBV_ILN_154
912			\|a GBV_ILN_168
912			\|a GBV_ILN_170
912			\|a GBV_ILN_171
912			\|a GBV_ILN_211
912			\|a GBV_ILN_290
912			\|a GBV_ILN_294
912			\|a GBV_ILN_601
912			\|a GBV_ILN_647
912			\|a GBV_ILN_754
912			\|a GBV_ILN_2001
912			\|a GBV_ILN_2002
912			\|a GBV_ILN_2003
912			\|a GBV_ILN_2004
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2007
912			\|a GBV_ILN_2008
912			\|a GBV_ILN_2015
912			\|a GBV_ILN_2016
912			\|a GBV_ILN_2018
912			\|a GBV_ILN_2020
912			\|a GBV_ILN_2026
912			\|a GBV_ILN_2095
912			\|a GBV_ILN_2116
912			\|a GBV_ILN_2120
912			\|a GBV_ILN_2121
912			\|a GBV_ILN_2219
912			\|a GBV_ILN_2221
912			\|a GBV_ILN_2279
912			\|a GBV_ILN_2286
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4035
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4219
912			\|a GBV_ILN_4251
912			\|a GBV_ILN_4277
912			\|a GBV_ILN_4302
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4314
912			\|a GBV_ILN_4317
912			\|a GBV_ILN_4320
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4700
951			\|a AR
952			\|d 535 \|j 2016 \|e 7611 \|h 214-217

South Africa ushers in a new era for HIV

Zugang & Verfügbarkeit

Zugehörige Publikationen/Bände